Differences in the prevalence of metabolic disorders between prepubertal boys and girls from 5 to 8 years of age

Acta Paediatrica, International Journal of Paediatrics

Volumn 103, Issue 4, 2014, Pages

  Maier, Ina B ^a   Özel, Yelda ^b   Engstler, Anna Janina ^b   Puchinger, Sonja ^a   Wagnerberger, Sabine ^a   Hulpke Wette, Martin ^c   Bischoff, Stephan C ^a   Bergheim, Ina ^b  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Paediatrician   (Germany)

Author keywords

Children; Inflammatory markers; Metabolic abnormality; Overweight; Sexual differences

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ABDOMINAL RADIOGRAPHY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERMANY; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PREPUBERTY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84896133353     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12546     Document Type: Article

References (30)

1. Reaven GM,. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 1997; 13: 65.
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
3. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH,. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-7.
4. Fernandez-Real JM, Ricart W,. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301.
5. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW,. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003; 27: 875-88.
6. Keating SE, Hackett DA, George J, Johnson NA,. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012; 57: 157-66.
7. Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F, et al. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. BMC Gastroenterol 2009; 9: 16.
8. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Konigsrainer A, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008; 138: 1452-5.
9. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F,. Percentile of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001; 149: 807-18.
10. Schwandt P, Kelishadi R, Haas GM,. First reference curves of waist circumference for German children in comparison to international values: the PEP Family Heart Study. World J Pediatr 2008; 4: 259-66.
11. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-76.
12. Raman A, Lustig RH, Fitch M, Fleming SE,. Accuracy of self-assessed Tanner staging against hormonal assessment of sexual maturation in overweight African-American children. J Pediatr Endocrinol Metab 2009; 22: 609-22.
13. Marshall WA, Tanner JM,. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
14. Marshall WA, Tanner JM,. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
15. Wabitsch M,. Leitlinien der Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter. AGA 2012. Available at http://www.adipositas-gesellschaft.de/ fileadmin/PDF/Leitlinien/AGA-S2-Leitlinie.pdf.
16. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD,. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26-31.
17. DDG. Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft. www deutsche-diabetes-gesellschaft de 2004.
18. D'Adamo E, Marcovecchio ML, Giannini C, Capanna R, Impicciatore M, Chiarelli F, et al. The possible role of liver steatosis in defining metabolic syndrome in prepubertal children. Metabolism 2010; 59: 671-6.
19. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, Sweeten S, et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 2010; 95: 1060-8.
20. Csabi G, Torok K, Jeges S, Molnar D,. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000; 159: 91-4.
21. Botton J, Heude B, Kettaneh A, Borys JM, Lommez A, Bresson JL, et al. Cardiovascular risk factor levels and their relationships with overweight and fat distribution in children: the Fleurbaix Laventie Ville Sante II study. Metabolism 2007; 56: 614-22.
22. Mantovani RM, Rios DR, Moura LC, Oliveira JM, Carvalho FF, Cunha SB, et al. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity. J Pediatr Endocrinol Metab 2011; 24: 361-7.
23. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI,. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 108-13.
24. DuBose KD, Stewart EE, Charbonneau SR, Mayo MS, Donnelly JE,. Prevalence of the metabolic syndrome in elementary school children. Acta Paediatr 2006; 95: 1005-11.
25. Pi-Sunyer FX,. Health implications of obesity. Am J Clin Nutr 1991; 53: 1595S-603S.
26. Mast M, Kortzinger I, Konig E, Muller MJ,. Gender differences in fat mass of 5-7-year old children. Int J Obes Relat Metab Disord 1998; 22: 878-84.
27. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007; 8: 299-306.
28. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A,. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96: 542-7.
29. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2012; 54: 700-13.
30. Abraham C, Rozmus CL,. Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes in obese children and adolescents? A systematic review J Sch Nurs 2012; 28: 195-205.